Minori Rosales
Chief Tech/Sci/R&D Officer at COMPASS THERAPEUTICS, INC.
Network origin in Minori Rosales first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 13 | |
| Extinct | Pharmaceuticals: Major | 11 | |
| Public Company | Pharmaceuticals: Major | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Minori Rosales via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Comptroller/Controller/Auditor | |
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Investment Managers | Founder Corporate Officer/Principal | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CORCEPT THERAPEUTICS INCORPORATED | Pharmaceuticals: Major | Investor Relations Contact | |
Meyers Associates LP
 Meyers Associates LP Investment Banks/BrokersFinance Founded in 1993, Meyers Associates LP is a full-service investment banking and securities brokerage firm located in New York City. The firm provides a full array of trading and execution services. They do not provide any internal research. | Investment Banks/Brokers | Corporate Officer/Principal | |
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Pharmaceuticals: Major | Director of Finance/CFO | |
Ladenburg Thalmann & Co., Inc. (Broker)
 Ladenburg Thalmann & Co., Inc. (Broker) Investment Banks/BrokersFinance Ladenburg Thalmann & Co., Inc. (Broker) is the broker/dealer division of Ladenburg Thalmann & Co., Inc., ultimately held by Advisor Group Holdings, Inc. Headquartered in New York City, the firm was founded in 1876 and offers a full suite of capital markets products and services, including proprietary equity research and a fixed-income trading desk. For institutional asset management clients, the firm provides liquidity, execution, high-quality idea-generating research, and access to corporate management teams. Their institutional coverage includes relationships with over asset management companies all over the world. To corporate clients, they bring access to investor capital, broad distribution capabilities and financial markets advisory. Ladenburg Thalmann is a leader in financing growing middle-market public companies across various industry verticals, including Healthcare & Life Sciences, Yield-Oriented Securities (BDCs, REITs, MLPs), Energy, Power & Infrastructure, and Telecom, Media & Technology. | Investment Banks/Brokers | Analyst-Equity | |
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer Director of Finance/CFO Director of Finance/CFO | |
Cello Health BioConsulting Inc.
 Cello Health BioConsulting Inc. Miscellaneous Commercial ServicesCommercial Services Cello Health BioConsulting Inc. operates as a business development strategy consulting firm. It offers opportunity assessments, portfolio and platform strategy, and identification and evaluation of In-licensing and acquisition opportunities. The company was founded by Ed Saltzman and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Doctorate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal | |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Director/Board Member | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| Center for Drug Evaluation & Research | General Government | Corporate Officer/Principal | |
The American Society for Clinical Pharmacology & Therapeutics
 The American Society for Clinical Pharmacology & Therapeutics Miscellaneous Commercial ServicesCommercial Services The American Society for Clinical Pharmacology & Therapeutics is a scientific and professional organization that serves the disciplines of clinical pharmacology and translational medicine. The non-profit company is based in Alexandria, VA. The CEO of the company is Sharon Swan. | Miscellaneous Commercial Services | President | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | General Counsel | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Yale School of Medicine | College/University | Doctorate Degree | |
| Joseph L. Mailman School of Public Health | College/University | Graduate Degree | |
| Columbia College (New York) | College/University | Undergraduate Degree | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree | |
Alopexx Enterprises LLC
 Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA. | Biotechnology | Director/Board Member | |
| KEROS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| ALOPEXX, INC. | Biotechnology | Director/Board Member | |
Aerium Therapeutics, Inc.
 Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya. | Miscellaneous Commercial Services | Director/Board Member | |
| NEUMORA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 47 |
| Italy | 2 |
| China | 2 |
Sectoral
| Health Technology | 20 |
| Finance | 11 |
| Consumer Services | 11 |
| Commercial Services | 7 |
| Government | 3 |
Operational
| Director/Board Member | 151 |
| Independent Dir/Board Member | 63 |
| Corporate Officer/Principal | 55 |
| Undergraduate Degree | 27 |
| Director of Finance/CFO | 23 |
Most connected contacts
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Mary Gray | 27 |
| Phil Ferneau | 20 |
| Peter Honig | 20 |
| Thomas Schuetz | 17 |
| Ellen Chiniara | 16 |
| Matthew Fust | 16 |
| Stephen Eck | 15 |
| Christopher S. James | 14 |
| Federica O’Brien | 14 |
| Jon Wigginton | 13 |
| Mark Sullivan | 11 |
| Vered Bisker-Leib | 11 |
| James Boylan | 10 |
| Richard Lindahl | 9 |
- Stock Market
- Insiders
- Minori Rosales
- Company connections
